Nav: Home

New grant supports young investigators committed to gastric and esophageal cancer research

August 26, 2013

Bethesda, MD (Aug. 26, 2013) -- The American Gastroenterological Association (AGA) Research Foundation is pleased to announce that it has partnered with the Gastric Cancer Foundation (GCF) to create a new grant to support research in gastric and esophageal cancer. The AGA Institute will match GCF's commitment of $1.125 million, resulting in a $2.25 million endowment to fund young investigators whose research will enhance the fundamental understanding of gastric (stomach) and esophageal cancer pathobiology in order to ultimately prevent or develop a cure for these diseases.

"We are pleased to join with the Gastric Cancer Foundation to create this new research scholar award in gastric and esophageal cancer," said Martin Brotman, MD, AGAF, chair, AGA Research Foundation. "This award will assure that we can fund young investigators who have the best ideas in upper GI cancer research and provide them with the tools needed to continue their research careers for years to come."

The National Cancer Institute estimates that in the U.S. in 2013, 21,600 new cases of stomach cancer and 17,990 news cases of esophageal cancer will be diagnosed, and more than 26,200 Americans will die from these diseases.

"Through our new partnership with AGA, we have a powerful opportunity to fund research that will make a difference in curing stomach cancer," said Wayne L. Feinstein, chairman, Gastric Cancer Foundation. "Despite its fatal consequences, in the U.S., stomach cancer receives just 0.4 percent of federal funding for cancer research. Funding for esophageal cancer is also alarmingly low. We are proud to join with AGA to advance research and carry out our mission."

The AGA-Gastric Cancer Foundation Research Scholar Award in Gastric and Esophageal Cancer will be provided to young researchers at the beginning of their careers who are interested in advancing the understanding of gastric or esophageal cancer for their fellow researchers, patients and the public. Recipients will receive $90,000 per year for three years to protect a major proportion of their time for research focused on better understanding these diseases.
Researchers interested in applying for the AGA-Gastric Cancer Foundation Research Scholar Award in Gastric and Esophageal Cancer should visit The application deadline is Dec. 13, 2013. Members of the AGA Research Awards Panel and representatives of the Gastric Cancer Foundation will review the proposals and select the award recipients. Funding will commence in July 2014.

This gift from the Gastric Cancer Foundation, along with AGA's matching support, will be invested for growth, with all interest from the endowment supporting future grants.

About the AGA Research Foundation

The AGA Research Foundation, formerly known as the Foundation for Digestive Health and Nutrition, is the cornerstone of AGA's effort to expand digestive disease research funding. Since 1984, the AGA, through its foundations, has provided more than $40 million in research grants to more than 770 scientists. The AGA Research Foundation serves as a bridge to the future of research in gastroenterology and hepatology by providing critical funding to advance the careers of young researchers between the end of training and the establishment of credentials that earn National Institutes of Health grants. Learn more about the AGA Research Foundation or make a contribution at

About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization.

Follow us on Twitter, @AmerGastroAssn. Become an AGA fan on Facebook.

About the Gastric Cancer Foundation

Since 2009, the Gastric Cancer Foundation (GCF) has led a call-to-action to build awareness of stomach cancer and to expand resources and understanding of the disease. In 2011, GCF launched the first national Gastric Cancer Registry, a data bank of information and tissue samples that fuels research to find new strategies for prevention, diagnosis and treatment. GCF is also primary contributor to a project that is creating a digital version of the gastric cancer genome based on DNA sequencing. GCF is devoted to funding stomach cancer research in pursuit of a cure. For more information about GCF or to make a donation, please visit

American Gastroenterological Association

Related Esophageal Cancer Articles:

Portable 'electronic nose' can accurately pick up esophageal cancer precursor
A portable 'electronic nose' can accurately pick up the precursor condition to food pipe (esophageal) cancer, known as Barrett's esophagus, indicates a proof of principle study, published online in the journal Gut.
A new machine learning approach detects esophageal cancer better than current methods
Dartmouth scientists have proposed a new machine learning model for identification of esophageal cancer that could open new avenues for applying deep learning to digital pathology.
Lymph nodes can predict survival in patients with esophageal cancer
It is difficult for physicians to estimate recurrence and survival in patients with esophageal cancer.
New model improves staging and risk predictions for esophageal cancer patients
A new nomogram for assessing metastatic risk in esophageal cancer patients shows promise for more accurate risk-stratification, which is particularly relevant for stage T2 patients.
Combo of virotherapy and radiotherapy shows early promise in patients with esophageal cancer
The experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early clinical efficacy in vulnerable patients with esophageal cancer, according to results from a phase I clinical trial presented at the AACR Annual Meeting 2019, March 29-April 3.
Drinking hot tea linked with elevated risk of esophageal cancer
Previous studies have revealed a link between hot tea drinking and risk of esophageal cancer, but until now, no study has examined this association using prospectively and objectively measured tea drinking temperature.
Newly identified drug targets could open door for esophageal cancer therapeutics
Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in the United States, according to new research out of Case Western Reserve University School of Medicine.
Test for esophageal cancer could save millions of lives
Cancer of the esophagus claims more than 400,000 lives around the world each year.
Genome offers clues to esophageal cancer disparity
A change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this population, a new study finds.
Detecting esophageal cancer cells
Researchers at the University of Texas at Arlington's College of Nursing and Health Innovation have developed a new nanoparticle-based platform for simultaneous imaging and treatment of esophageal cancer.
More Esophageal Cancer News and Esophageal Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at